Ovagen
Liver & digestive tract Research only Preliminary Synthetic short peptide (Cytogen)
Also called EDL peptide
A three-amino-acid Khavinson peptide associated with liver and digestive tract function. It shares a name with an unrelated sheep-derived fertility hormone product, so check which one a source means.
Evidence at a glance
- Evidence
- Preliminary — Very little published work
- Status
- Research compound only
- Dosing
- No human study has set a dose
Little published data. Do not confuse with the sheep FSH product of the same name.
What studies report
- Associated with normalising liver and digestive tract function in Russian reports
How it works
A Khavinson short peptide: at two to four amino acids it is small enough to pass through cell and nuclear membranes intact. The proposed mechanism is that it binds specific sites on nuclear DNA and changes which genes are switched on in its target tissue, rather than acting on a surface receptor the way most peptides do.
Where it acts
LiverThe library groups this compound under Liver & digestive tract. The diagram shows that target, not every tissue it reaches.
Illustrated
AI-generated subject illustration; not a depiction of the compound or evidence of its effects.
Why people take it
Reasons people seek it out — not a list of proven effects.
Status: Limited data, mostly from one research group.
- Route
- Subcutaneous injection, or oral capsule depending on the preparation
- Sequence
- Glu-Asp-Leu
- Formula
- C15H25N3O8
- Molecular weight
- 375.37 g/mol
- Available as
- 20 mg
Search PubMed for Ovagen → We link a live search rather than a fixed citation list, so it stays current and nothing here is a reference we have not checked.
Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.